BFC Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4M Buy
46,571
+5,389
+13% +$475K 0.16% 128
2026
Q2
$3.22M Buy
41,182
+1,164
+3% +$93.9K 0.13% 166
2026
Q1
$3.47M Sell
40,018
-63,316
-61% -$6.07M 0.15% 135
2025
Q4
$9.9M Buy
103,334
+99,586
+2,657% +$9.7M 0.44% 42
2025
Q3
$357K Sell
3,748
-66
-2% -$6.07K 0.03% 479
2025
Q2
$333K Sell
3,814
-1,827
-32% -$155K 0.03% 458
2025
Q1
$507K Buy
5,641
+56
+1% +$5.01K 0.04% 328
2024
Q4
$446K Buy
5,585
+174
+3% +$15.1K 0.04% 361
2024
Q3
$487K Buy
+5,411
New +$455K 0.04% 346

Other funds holding MDT

BFC Planning's MDT Position: Q3 2026 in Review

BFC Planning increased its Medtronic (MDT) stake by 13% in Q3 2026, buying an estimated $475K and bringing the position to 46,571 shares worth $4M. The position accounts for 0.16% of the portfolio, ranked #128.

BFC Planning first reported a position in MDT in Q3 2024 and has held it in 9 quarters since. The position peaked at $9.9M in Q4 2025. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • BFC Planning held 46,571 shares of Medtronic worth $4M as of Q3 2026.
  • BFC Planning bought 5,389 Medtronic shares in Q3 2026, an estimated $475K.
  • Medtronic made up 0.16% of BFC Planning's portfolio in Q3 2026, its #128 holding.
  • BFC Planning first reported a position in Medtronic in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Medtronic position peaked at $9.9M in Q4 2025.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.